Indication

Benign hydatidiform mole

A benign hydatidiform mole, also known as a molar pregnancy, is a noninvasive gestational trophoblastic disease arising from aberrantly fertilized ovular tissue in pregnant females. Read more about Benign hydatidiform mole

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Benign hydatidiform mole therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Benign hydatidiform mole preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Benign hydatidiform mole.

A benign hydatidiform mole, also known as a molar pregnancy, is a noninvasive gestational trophoblastic disease arising from aberrantly fertilized ovular tissue in pregnant females.

It affects the placenta and uterine cavity, manifesting either as a complete mole without fetal tissue or a partial mole with coexisting, typically nonviable embryonic components.

Pathophysiologically, the condition is driven by excessive paternal genetic material that causes hydropic swelling of chorionic villi, diffuse or focal trophoblastic hyperplasia, and hypersecretion of human chorionic gonadotropin.

Clinically, it frequently presents with first-trimester vaginal bleeding, uterine enlargement disproportionate to gestational age, hyperemesis gravidarum, or characteristic vesicular patterns on pelvic ultrasound.

Personalize your experience

Follow Benign hydatidiform mole and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it